Overexpression of the MET receptor due to gene amplification can activate various downstream signaling pathways, including the PI3K/AKT pathway and the RAS/MAPK pathway. These pathways are involved in cell proliferation, survival, and migration, contributing to tumorigenesis and metastasis. Additionally, MET amplification can lead to resistance to certain targeted therapies, complicating cancer treatment strategies.
